Published in J Bone Joint Surg Am on June 01, 2000
Metal-on-metal hip arthroplasty does equally well in osteonecrosis and osteoarthritis. Clin Orthop Relat Res (2008) 1.53
MRI predicts ALVAL and tissue damage in metal-on-metal hip arthroplasty. Clin Orthop Relat Res (2014) 1.36
Do "premium" joint implants add value?: analysis of high cost joint implants in a community registry. Clin Orthop Relat Res (2011) 1.28
Survival of hard-on-hard bearings in total hip arthroplasty: a systematic review. Clin Orthop Relat Res (2011) 1.28
Failure of the Durom Metasul acetabular component. Clin Orthop Relat Res (2009) 1.15
Revisions of monoblock metal-on-metal THAs have high early complication rates. Clin Orthop Relat Res (2015) 1.15
Predictors of participation in sports after hip and knee arthroplasty. Clin Orthop Relat Res (2012) 1.03
2008 John Charnley award: metal ion levels after metal-on-metal total hip arthroplasty: a randomized trial. Clin Orthop Relat Res (2008) 1.00
Osteolysis with a cementless second generation metal-on-metal cup in total hip replacement. Int Orthop (2008) 1.00
Metal-on-metal hip arthroplasty: does early clinical outcome justify the chance of an adverse local tissue reaction? Clin Orthop Relat Res (2009) 0.97
Causes of failure of ceramic-on-ceramic and metal-on-metal hip arthroplasties. Clin Orthop Relat Res (2012) 0.94
Risk factors for revision of hip arthroplasties in patients younger than 30 years. Clin Orthop Relat Res (2010) 0.92
How have alternative bearings and modularity affected revision rates in total hip arthroplasty? Clin Orthop Relat Res (2014) 0.90
Serum ion level after metal-on-metal THA in patients with renal failure. Clin Orthop Relat Res (2008) 0.85
Metal-on-Metal Bearing: Is This the End of the Line? We Do Not Think So. HSS J (2012) 0.83
Metal-on-Metal Total Hip Resurfacing Arthroplasty: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2006) 0.80
CoCrMo metal-on-metal hip replacements. Phys Chem Chem Phys (2013) 0.78
Total hip arthroplasty: areview of advances, advantages and limitations. Int J Clin Exp Med (2015) 0.77
The clinical performance of metal-on-metal as an articulation surface in total hip replacement. Iowa Orthop J (2005) 0.77
Cemented metal-on-metal total hip replacement with 28-mm head: prospective, long-term, clinical, radiological and metal ions data. Eur J Orthop Surg Traumatol (2014) 0.77
Prosthetic design and outcome in total hip arthroplasty. J Bone Joint Surg Am (2001) 0.75
Adverse Reactions to Metal on Metal Are Not Exclusive to Large Heads in Total Hip Arthroplasty. Clin Orthop Relat Res (2016) 0.75
High Re-Operation Rates Using Conserve Metal-On-Metal Total Hip Articulations. Open Orthop J (2016) 0.75
Comparison of metal ion concentrations and implant survival after total hip arthroplasty with metal-on-metal versus metal-on-polyethylene articulations. Acta Orthop (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology (2003) 6.51
Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (1995) 3.42
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol (2001) 2.66
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
The mental representation of hand movements after parietal cortex damage. Science (1996) 2.28
The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A (2002) 2.26
Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci U S A (2001) 2.12
Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol (1997) 1.94
Brain networks of spatial awareness: evidence from diffusion tensor imaging tractography. J Neurol Neurosurg Psychiatry (2007) 1.94
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol (2000) 1.89
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 1.85
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol (1994) 1.81
VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study. Neurology (2008) 1.79
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology (2011) 1.72
Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med (1997) 1.69
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res (1983) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Coupled temporal memories in Parkinson's disease: a dopamine-related dysfunction. J Cogn Neurosci (1998) 1.64
Motor signs predict poor outcomes in Alzheimer disease. Neurology (2005) 1.60
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet (1995) 1.55
Causes of and treatment protocol for instability of total hip replacement. Clin Orthop Relat Res (1998) 1.53
Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia (2002) 1.51
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry (1984) 1.49
Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry (2013) 1.48
Motor signs during the course of Alzheimer disease. Neurology (2004) 1.47
Ropinirole without levodopa in Parkinson's disease. Lancet (1990) 1.46
Delayed response tasks and prefrontal lesions in man--evidence for self generated patterns of behaviour with poor environmental modulation. Neuropsychologia (1993) 1.45
The role of dorsolateral prefrontal cortex in the preparation of forthcoming actions: an fMRI study. Cereb Cortex (2001) 1.42
Brain spect perfusion of frontotemporal dementia associated with motor neuron disease. Neurology (2007) 1.41
Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res (2004) 1.41
Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol (2000) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry (1995) 1.38
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology (1986) 1.35
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord (1994) 1.32
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry (2005) 1.31
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol (1993) 1.31
Congruent unilateral impairments for real and imagined hand movements. Neuroreport (1995) 1.30
Medial protrusio technique for placement of a porous-coated, hemispherical acetabular component without cement in a total hip arthroplasty in patients who have acetabular dysplasia. J Bone Joint Surg Am (1999) 1.29
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology (1991) 1.28
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet (1998) 1.27
Somatostatin and dementia in Parkinson's disease. Brain Res (1983) 1.25
Preserved adjustment but impaired awareness in a sensory-motor conflict following prefrontal lesions. J Cogn Neurosci (2001) 1.24
Retrieval of geophysical parameters from moderate resolution imaging spectroradiometer thermal infrared data: evaluation of a two-step physical algorithm. Appl Opt (2000) 1.21
Ten years of experience with porous acetabular components for revision surgery. Clin Orthop Relat Res (1995) 1.18
TDP-43 M311V mutation in familial amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.17
Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait. Int J Epidemiol (1999) 1.16
Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.15
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol (1990) 1.14
Technical factors for success with metal ring acetabular reconstruction. J Arthroplasty (2001) 1.14
Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol (1999) 1.13
Human genetic factors related to susceptibility to mild malaria in Gabon. Genes Immun (2000) 1.13
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry (1989) 1.13
A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res (1983) 1.12
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. Arch Neurol (1998) 1.09
In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J Interferon Cytokine Res (2000) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Harmonized diagnostic criteria for Alzheimer's disease: recommendations. J Intern Med (2014) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS (2001) 1.07
Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol (1997) 1.06
Lesions of basal ganglia due to disulfiram neurotoxicity. J Neurol Neurosurg Psychiatry (1992) 1.05
Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol (1987) 1.05
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. J Neurol (2000) 1.04
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry (1998) 1.04
Malaria and pregnancy in Cameroonian primigravidae: humoral and cellular immune responses to Plasmodium falciparum blood-stage antigens. Am J Trop Med Hyg (1995) 1.04
Dendritic cells enhance the differentiation of naïve B cells into plasma cells in vitro. Scand J Immunol (1998) 1.04
Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology (2005) 1.03
The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology (1995) 1.03
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain (2007) 1.02
DTI-MR tractography of white matter damage in stroke patients with neglect. Exp Brain Res (2010) 1.02
Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02
Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria. Trans R Soc Trop Med Hyg (2000) 1.02
Rehabilitation after total knee arthroplasty: a comparison of 2 rehabilitation techniques. Clin Orthop Relat Res (1996) 1.02
Accumulation of flotillin-1 in tangle-bearing neurones of Alzheimer's disease. Neuropathol Appl Neurobiol (2003) 1.01
Anti-malaria antibody-producing B cell frequencies in adults after a Plasmodium falciparum outbreak in Madagascar. Clin Exp Immunol (1995) 1.01
Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria. Eur Cytokine Netw (1998) 1.01
Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. Am J Trop Med Hyg (1999) 1.01
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology (1989) 1.01
Three cases of spontaneous extracranial vertebral artery dissection. Stroke (1990) 1.01
Immune response to Plasmodium falciparum antigens in Cameroonian primigravidae: evolution after delivery and during second pregnancy. Clin Exp Immunol (1997) 1.00
Familial effects on the clinical course of multiple sclerosis. Neurology (2007) 1.00
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99